In the NASH-noF group, there was a trend for a decreased ABTpeak and ABTcum between patients with borderline NASH and definite NASH, though these differences did not reach statistical significance [9.20 (6.58; 11.45) vs. 7.65 (5.50; 10.48) %dose/h for ABTpeak ( p = 0.077); and 12.90 (10.00; 16.55) vs. 10.95 (8.55; 15.13)%dose/120 min for ABTcum ( p = 0.085), respectively].
← all excerpts
Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis.
1
0.0770
0.0770